http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2023501334-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2023-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2023501334-A |
titleOfInvention | Treatment of autoinflammatory diseases |
abstract | The present invention relates to cryopyrin-associated periodic fever syndrome (CAPS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), hyperimmune globulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), familial Mediterranean fever (FMF) ), Behcet's disease, pyoderma gangrenosum, systemic juvenile idiopathic arthritis (sJIA), Schnitzler's syndrome, or hidradenitis suppurativa, for use in the treatment or prevention of autoinflammatory diseases, such as formula (I) relating to the compound of [Selection] FIGS. 1A and 1B |
priorityDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.